First Hawaiian Bank Purchases 2,849 Shares of HCA Healthcare, Inc. $HCA

Key Points

• First Hawaiian Bank increased its stake in HCA Healthcare by 55.3% in Q1, acquiring an additional 2,849 shares, bringing its total holdings to 7,999 shares valued at approximately $2.76 million.
• HCA Healthcare's recent earnings report showed an EPS of $6.84, exceeding estimates of $6.20, with revenue rising 6.4% year-over-year to $18.61 billion.
• The company announced a quarterly dividend of $0.72 per share, reflecting a 0.7% yield, with the payment set for September 30th.

First Hawaiian Bank boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 55.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,999 shares of the company's stock after acquiring an additional 2,849 shares during the quarter. First Hawaiian Bank's holdings in HCA Healthcare were worth $2,764,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare during the first quarter valued at about $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare during the first quarter valued at about $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare during the first quarter valued at about $27,000. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the first quarter worth about $28,000. Finally, Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Activity

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.30% of the company's stock.

Analysts Set New Price Targets

HCA has been the topic of several recent analyst reports. Royal Bank Of Canada cut their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Bank of America raised their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research note on Wednesday. Barclays cut their target price on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday, July 28th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, Wells Fargo & Company lowered their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $403.17.

HCA Healthcare Price Performance

HCA stock opened at $405.54 on Friday. The firm has a 50 day moving average price of $382.88 and a 200-day moving average price of $362.77. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98. The firm has a market capitalization of $94.89 billion, a price-to-earnings ratio of 17.05, a PEG ratio of 1.27 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the business earned $5.50 earnings per share. The business's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.